Mark Stewart: We released our Friends of Cancer Research 2023 Scientific Report
Mark Stewart, Vice President of Friends of Cancer Research, shared a post on LinkedIn:
“We released our Friends of Cancer Research 2023 Scientific Report today. The report contains all of our white papers and publications to serve as a resource for those in the drug development and regulatory space.
Over the course of 2023 our work touched on several key themes:
1. Patient-Focused Drug Development: Advancing Patient-Centered Technologies and Trial Designs
2. Real-World Evidence: Leveraging RWD for Insights on Real-World Response
3. Innovative Drug Development: Insights for Advancing Oncology Trials and Therapies
4. Complex Biomarkers: Aligning Best Practices to Support Future Utilization
Through our collaborations and expertise from our partners, we are able to develop proposals and solutions that help shape and inform the landscape of oncology drug development and regulatory policy to bring advancements in treatment to patients.
Read the full report here:”
Source: Mark Stewart/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023